Knowledge

Sandhoff disease

Source đź“ť

428:
material from an infantile case with amaurotic idiocy. The glycolipid analysis soon demonstrated differences from all the cases studied before. Besides the neuronal storage of GM2, the storage of GA2 was much more pronounced, and different from all cases of Tay-Sachs disease studied so far, globoside accumulated in the visceral organs and, most importantly, hexosaminidase activity was almost completely absent. The disease causing catabolic enzyme deficiency of hexosaminidases was demonstrated with four different substrates (p–nitrophenyl-β-D-N-acetylglucosaminide, p-nitrophenyl-β-D-N-acetylgalactosaminide, glycolipid GA2 and globoside) in four different organs and published in 1968.
71: 104:. The classic infantile form of the disease has the most severe symptoms and is incredibly hard to diagnose at this early age. The first signs of symptoms begin before 6 months of age and the parents’ notice when the child begins regressing in their development. If the children had the ability to sit up by themselves or crawl they will lose this ability. This is caused by a slow deterioration of the muscles in the child's body from the buildup of GM2 47: 399:
suffer from aspiration or lack the ability to change from the passageway to their lungs versus their stomach and their spit travels to the lungs causing bronchopneumonia. The patient also lacks the ability to cough and therefore must undergo a treatment to shake up their body to remove the mucus from the lining of their lungs. Medication is also given to patients to lessen their symptoms including seizures.
116:, it is unable to attach to these gangliosides to break them apart and make them non-toxic. With this buildup there are several symptoms that begin to appear such as muscle/motor weakness, sharp reaction to loud noises, blindness, deafness, inability to react to stimulants, respiratory problems and infections, mental retardation, seizures, cherry red spots in the retina, enlarged liver and spleen ( 416: 424:
analysis of various patients with amaurotic idiocy by Konrad Sandhoff (born 1939), a German biochemist, led to the identification of several biochemically distinct diseases: the first biochemical description of GM1-gangliosidosis in 1963, Sandhoff disease in 1968, Tay-Sachs-Disease, the AB-variant of GM2-Gangliosidosis and the B1-variant of GM2-gangliosidosis.
427:
The molecular defect in Sandhoff disease was discovered when Sandhoff studied the biochemistry of sphingolipids and gangliosides in the laboratory of Prof. Horst Jatzkewitz (1912–2002), a German biochemist (Max Planck Institute for Psychiatry, Munich). In October 1966, he obtained deep-frozen autopsy
307:
screening if they are at high risk, to determine their carrier status before they have children. However, it is also highly recommended to undergo testing even for those parents who do not have a family history of Sandhoff disease. Over 95% of the families that have children with Sandhoff disease had
229:
rather than a high population frequency, because Ashkenazi Jews were the targeted population in a mass screening program for Tay-Sachs disease. Several rare SD mutations were discovered as researchers resolved cases of enzyme deficiency among suspected TSD carriers, but no cases of the disease itself
398:
to manage seizures or medications to treat respiratory infections, and consume a precise diet consisting of puree foods due to difficulties swallowing. Infants with the disease usually die by the age of 3 due to respiratory infections. The patient must be under constant surveillance because they can
233:
However, since it is an autosomal recessive disease, it is likely found in any ethnic group passing from generation to generation through carriers without being expressed in their offspring. Even though the family may not have a history of Sandhoff disease, it is possible for two individuals to have
171:
particularly within the C1214T allele caused the adult onset form of Sandhoff Disease. For the patient showing symptoms of the infantile or juvenile form they have a mutation on exon I207V from their father, and a 16 base pair deletion from their mother which can be located on as many as five exons,
406:
in mice, as well as stem cell treatment in humans and other medical treatments recruiting test patients. A Sandhoff disease study showing proof of principle for gene therapy in a human model system using CRISPR and virus gene correction gives the chance for clinical trials to cure the disease. The
423:
Sandhoff disease is one of several forms of what was formerly known as amaurotic idiocy. This inherited disease is characterized by the accumulation of lipid-containing cells in the viscera and in the nervous system, mental retardation, and impaired vision or blindness. The chemical and enzymatic
302:
to determine if the above-noted compounds are abnormally stored within the body. For a child to suffer from this disease, both parents must be carriers, and both must transmit the mutation to the child. Thus, even in the case where both parents have the mutation, there is only a 25 percent chance
131:
The other two forms of Sandhoff disease have similar symptoms but to a lesser extent. Adult and juvenile forms of Sandhoff disease are more rare than the infantile form. In these cases victims suffer cognitive impairment (retardation) and a loss of muscle coordination that impairs and eventually
87:
caused by the inherited deficiency to create functional beta-hexosaminidases A and B. These catabolic enzymes are needed to degrade the neuronal membrane components, ganglioside GM2, its derivative GA2, the glycolipid globoside in visceral tissues, and some oligosaccharides. Accumulation of these
312:
gene does not cause clinical symptoms when only one copy is present, and often passed undetected from one generation to the next Naturally, if an individual carries the mutation, he or she has a risk of transmitting it to the unborn child. Genetic counseling is recommended for those who have the
335:
Classic infantile form of the disease is classified by the development of symptoms anywhere from 2 months to 9 months of age. It is the most common and most severe of all of the forms and will lead to death before the patient reaches the age of three. Infants with this disorder typically appear
316:
It is possible for parents who are about to have a child or had a child with Sandhoff Disease can have a PGD or PEGD. PEGD is pre-embryonic genetic diagnosis for the parents that would not benefit from a pre-implantation genetic diagnosis because of their religion or negative attitude for the
380:
Juvenile and adult onset forms of Sandhoff disease are very rare. Signs and symptoms can begin in childhood, adolescence, or adulthood and are usually milder than those seen with the infantile form of Sandhoff disease. As in the infantile form, mental abilities and coordination are affected.
393:
Currently Sandhoff disease does not have any standard treatment and does not have a cure. However, a person suffering from the disease needs proper nutrition, hydration, and maintenance of clear airways. To reduce some symptoms that may occur with Sandhoff disease, the patient may take
375:
Adult onset form of the disease is classified by its occurrence in older individuals and has an effect on the motor function of these individuals. It is not yet known if Sandhoff disease will cause these individuals to have a decrease in their life
132:
destroys their ability to walk; the characteristic red spots in the retina also develop. The adult form of the disease, however, is sometimes milder, and may only lead to muscle weakness that impairs walking or the ability to get out of bed.
1538: 1523: 1508: 321:
to be produced by two parents if they were to conceive a child. If the family has a history of Sandhoff disease it is recommended they have their genome sequenced to ensure they are not carriers or to sequence the genome of their child.
367:
The juvenile form of the disease shows symptoms starting at age 3 ranging to age 10 and, although the child usually dies by the time they are 15, it is possible for them to live longer if they are under constant care. Symptoms include
568:
Pilz H, MĂĽller D, Sandhoff K, ter Meulen V (September 1968). "Tay-Sachssche Krankheit mit Hexosaminidase-Defekt (Klinische, morphologische und biochemische Befunde bei einem Fall mit viszeraler Speicherung von Nierenglobosid)".
259:, which function in nerve cells to break down fatty substances, complex sugars, and molecules that are linked to sugars. In particular, beta-hexosaminidase A breaks down a fatty compound called GM2 ganglioside. Mutations in the 155:
in the HEX B gene located within chromosome 5 (see figure bottom), leading to the differences in severities of the symptoms. The difference in the codons has the consequence of inhibiting two enzymes located in the
330:
There are three types of Sandhoff disease: classic infantile, juvenile, and adult late onset. Each form is classified by the severity of the symptoms as well as the age at which the patient shows these symptoms.
979:
Chamoles NA, Blanco M, Gaggioli D, Casentini C (April 2002). "Tay-Sachs and Sandhoff diseases: enzymatic diagnosis in dried blood spots on filter paper: retrospective diagnoses in newborn-screening cards".
878:
Kleiman FE, et al. (1994). "Sandhoff disease in Argentina: high frequency of a splice site mutation in the HEXB gene and correlation between enzyme and DNA-based tests for heterozygote detection".
92:, another genetic disorder that disrupts beta-hexosaminidases A and S. There are three subsets of Sandhoff disease based on when first symptoms appear: classic infantile, juvenile and adult late onset. 88:
metabolites leads to a progressive destruction of the central nervous system and eventually to death. The rare autosomal recessive neurodegenerative disorder is clinically almost indistinguishable from
471:
Sandhoff K, Andreae U, Jatzkewitz H (March 1968). "Deficient hexosaminidase activity in an exceptional case of Tay-Sachs disease with additional storage of kidney globoside in visceral organs".
957:
Cantor RM, Kaback MM (1985). "Sandhoff disease (SHD) heterozygote frequencies (HF) in North American (NA) Jewish (J) and non-Jewish (NJ) populations: implications for carrier (C) screening".
185:
Articles regarding Sandhoff disease frequencies among distinct groups of people contain discrepancies from one another. More than 25 mutations have been reported other than novel mutations.
266:
As a result, progressive damage caused by the resulting buildup of GM2 ganglioside leads to the destruction of nerve cells, causing the signs and symptoms associated with Sandhoff disease.
1186:
Allende, Maria L.; Cook, Emily K.; Larman, Bridget C.; Nugent, Adrienne; Brady, Jacqueline M.; Golebiowski, Diane; Sena-Esteves, Miguel; Tifft, Cynthia J.; Proia, Richard L. (2018-01-22).
1485: 922:
Drousiotou A, et al. (2000). "Sandhoff disease in Cyprus: population screening by biochemical and DNA analysis indicates a high frequency of carriers in the Maronite community".
1362:"AB variant of infantile GM2 gangliosidosis: deficiency of a factor necessary for stimulation of hexosaminidase A-catalyzed degradation of ganglioside GM2 and glycolipid GA2" 1050:
Zhang, Zhi-Xin; Nobuaki Wakamatsu; Emilie H. Mulesi; George H. Thomasi; Roy A. Gravel (1994). "Impact of premature stop codons on mRNA levels in infantile Sandhoff disease".
612:
Harzer K, Sandhoff K, Schall H, Kollmann F (November 1971). "Enzymatische Untersuchungen im Blut von Überträgern einer Variante der Tay-Sachsschen Erkrankung (Variante 0)".
1638: 682:
Gomez-Lira M, Sangalli A, Mottes M, Perusi C, Pignatti PF, Rizzuto N, Salviati A (1995). "A common β hexosaminidase gene mutation in adult Sandhoff disease patients".
385:) and other problems with movement, speech problems, and mental illness. These signs and symptoms vary widely among people with late-onset forms of Sandhoff disease. 1245: 164:
contain various enzymes to break down byproducts and toxins to ensure they do not accumulate enough to interfere with the function of the central nervous system.
1775: 234:
a child with the disease. Since Sandhoff disease was only discovered in 1968, there are years the disease has gone undetected because of misdiagnoses.
1969: 1110:
Hendriksz CJ, Corry PC, Wraith JE, Besley GT, Cooper A, Ferrie CD (2004). "Juvenile Sandhoff disease-Nine New Cases and a review of the literature".
1883: 360:, which can be identified with an eye examination, is characteristic of this disorder. Some infants with Sandhoff disease may have enlarged organs ( 140:
Two parents carrying a mutated gene and passing it on to their offspring cause the disease. Even with both parents carrying the disease in their
1949: 175: 1631: 1959: 1616: 832: 1553: 659: 1170: 1914: 1085: 1780: 1954: 1918: 1655: 1624: 1888: 1015:
Kuliev A, Rechitsky S, Laziuk K, Verlinsky O, Tur-Kaspa I, Verlinsky Y (2006). "Pre-Embryonic diagnosis for Sandhoff Disease".
1909: 1875: 1721: 437: 344:
such as turning over, sitting, and crawling. As the disease progresses, infants develop seizures, vision and hearing loss,
144:, there is only a 25% chance that they will have a child containing the genetic coding for the disease (see figure right). 1830: 1309:
Okada S, O'Brien JS (August 1969). "Tay-Sachs disease: generalized absence of a beta-D-N-acetylhexosaminidase component".
274:
Sandhoff disease can be detected through the following procedures (before it is apparent through physical examination): a
1253: 1825: 1188:"Cerebral organoids derived from Sandhoff disease induced pluripotent stem cells exhibit impaired neurodifferentiation" 1651: 1647: 1771: 147:
Each form of the disease is caused by the differences in the various mutations of the genome, in particular the
1564: 403: 364:) or bone abnormalities. Children with the severe form of this disorder usually live only into early childhood. 202: 1246:"Sandhoff disease study shows proof of principle for gene therapy - Scienmag: Latest Science and Health News" 263:
gene disrupt the activity of these enzymes, preventing the breakdown of GM2 ganglioside and other molecules.
1964: 1928: 1659: 1480: 113: 84: 1716: 101: 89: 1741: 1604: 1274:
Jatzkewitz H, Sandhoff K (June 1963). "On a biochemically special form of infantile amaturotic idiocy".
256: 252: 1790: 1421:"Variant of GM2-gangliosidosis with hexosaminidase A having a severely changed substrate specificity" 1373: 1318: 524: 1542: 251:
cause Sandhoff disease. The gene provides instructions for making a protein crucial to the enzymes
188:
One article says that Sandhoff disease is found commonly in individuals with a non-Jewish descent.
70: 1153:
Karbani, Gulshan A (15 May 2012). "Genetic Counselling: Consanguinity and Cultural Expectations".
1835: 1707: 1702: 1342: 1135: 904: 707: 637: 594: 550: 291: 226: 117: 303:
their child will inherit the condition. Frequently, parents are given the opportunity to have a
1575: 1450: 1401: 1334: 1291: 1227: 1209: 1166: 1127: 1067: 1032: 997: 939: 896: 836: 811: 699: 629: 586: 542: 488: 59: 728: 1786: 1668: 1440: 1432: 1391: 1381: 1326: 1283: 1217: 1199: 1158: 1119: 1059: 1024: 989: 931: 888: 801: 691: 621: 578: 532: 480: 125: 1532: 395: 357: 283: 46: 1123: 1089: 1377: 1322: 1162: 528: 1922: 1893: 1861: 1839: 1811: 1689: 1436: 1222: 1187: 806: 789: 287: 222: 1547: 1445: 1420: 1396: 1361: 1028: 993: 1943: 1764: 1756: 1745: 1287: 598: 537: 512: 484: 64: 1139: 711: 554: 1806: 1346: 908: 749: 641: 361: 341: 295: 206: 168: 105: 174: 1569: 1330: 1849: 1698: 1684: 1580: 415: 1517: 381:
Characteristic features include muscle weakness, loss of muscle coordination (
299: 1213: 1821: 1801: 1733: 1527: 442: 353: 349: 196: 161: 121: 1386: 1295: 1231: 1131: 1036: 1001: 943: 582: 546: 1454: 1338: 1071: 1063: 935: 900: 703: 633: 590: 492: 1857: 1673: 1599: 815: 345: 211: 157: 1405: 1204: 407:
ultra-rare occurrence is a main hurdle to overcome for clinical trials.
892: 695: 625: 513:"Variation of beta-N-acetylhexosaminidase-pattern in Tay-Sachs disease" 308:
no known prior family history of the condition, as the mutation in the
109: 1500: 372:, ataxia, motor skills regression, spacticity, and learning disorders. 1512: 382: 369: 337: 318: 275: 215: 148: 141: 336:
normal until the age of 3 to 6 months, when development slows and
279: 152: 402:
Currently the government is testing several treatments including
1558: 663: 248: 244: 167:
Using restriction enzymes, it was discovered that a mutation on
54:
Sandhoff disease is inherited via an autosomal recessive manner.
1620: 304: 1419:
Kytzia HJ, Hinrichs U, Maire I, Suzuki K, Sandhoff K (1983).
100:
Sandhoff disease symptoms are clinically indeterminable from
835:. Department of Neurology Jefferson Hospital. Archived from 860:. National Tay-Sachs & Allied Disease Association, Inc 1467: 317:
discarding of embryos. PEGD sequences the genome of the
857: 1466:
This article incorporates some public domain text from
1086:"From a parents perspective: Parents view of Sandhoff" 1490: 290:
and tissues (to determine the presence of a genetic
1902: 1874: 1847: 1799: 1754: 1731: 1682: 1667: 1590: 1494: 58: 26: 21: 340:used for movement weaken. Affected infants lose 160:of the neurons of the central nervous system. 1632: 8: 827: 825: 1679: 1639: 1625: 1617: 1491: 1088:. sandhoffdisease.webs.com. Archived from 108:. Since the body is unable to create the 69: 45: 18: 1444: 1395: 1385: 1221: 1203: 805: 783: 781: 774:. Lippincott Williams & Wilkin. 2008. 536: 1360:Conzelmann E, Sandhoff K (August 1978). 1250:Scienmag: Latest Science and Health News 414: 191:Others say that it is more commonly in: 833:"Lysosomal Diseases Testing Laboratory" 790:"Carrier detection in Sandhoff disease" 677: 675: 673: 671: 454: 1112:Journal of Inherited Metabolic Disease 974: 972: 723: 721: 655: 653: 651: 1468:The U.S. National Library of Medicine 506: 504: 502: 278:removing a sample of tissue from the 242:Biallelic pathogenic variants in the 7: 466: 464: 462: 460: 458: 1163:10.1002/9780470015902.a0006179.pub2 660:Online Mendelian Inheritance in Man 1437:10.1002/j.1460-2075.1983.tb01567.x 1124:10.1023/B:BOLI.0000028777.38551.5a 959:American Journal of Human Genetics 794:American Journal of Human Genetics 729:"Introduction to Sandhoff Disease" 221:Discovery of several mutations in 195:the Creole population of northern 14: 1915:Cholesteryl ester storage disease 39:hexosaminidase A and B deficiency 1970:Diseases named after discoverers 1919:Lysosomal acid lipase deficiency 770:"Symptoms of Sandhoff Disease". 173: 1017:Reproductive BioMedicine Online 788:Lowden JA, et al. (1978). 731:. The Medical Biochemistry Page 35:variant 0 of GM2-gangliosidosis 1910:Cerebrotendinous xanthomatosis 438:GM2-gangliosidosis, AB variant 1: 1950:Autosomal recessive disorders 1831:Multiple sulfatase deficiency 1155:Encyclopedia Of Life Sciences 1029:10.1016/S1472-6483(10)61005-X 994:10.1016/S0009-8981(02)00002-5 1826:Metachromatic leukodystrophy 1331:10.1126/science.165.3894.698 1288:10.1016/0006-3002(63)90764-9 1252:. 2018-02-22. Archived from 538:10.1016/0014-5793(69)80274-7 485:10.1016/0024-3205(68)90024-6 1960:Neurodegenerative disorders 1889:Jansky–Bielschowsky disease 31:Sandhoff–Jatzkewitz disease 1986: 1648:Lysosomal storage diseases 511:Sandhoff K (August 1969). 181:Mutations and polymorphism 1192:Journal of Lipid Research 752:. Genetics Home Reference 664:Sandhoff Disease - 268800 53: 44: 1366:Proc Natl Acad Sci U S A 1052:Human Molecular Genetics 404:N-butyl-deoxynojirimycin 286:, molecular analysis of 83:is a lysosomal genetic, 1955:Lipid storage disorders 1660:Lipid storage disorders 1929:Sea-blue histiocytosis 1387:10.1073/pnas.75.8.3979 772:Medical Books Excerpts 583:10.1055/s-0028-1110836 420: 114:central nervous system 85:lipid storage disorder 1742:Globotriaosylceramide 936:10.1007/s004390050003 418: 356:abnormality called a 298:, and occasionally a 257:beta-hexosaminidase B 253:beta-hexosaminidase A 1772:Niemann–Pick disease 1276:Biochim Biophys Acta 982:Clinica Chimica Acta 571:Dtsch Med Wochenschr 230:have been reported. 112:it needs within the 1378:1978PNAS...75.3979C 1323:1969Sci...165..698O 1205:10.1194/jlr.M081323 1064:10.1093/hmg/3.1.139 529:1969FEBSL...4..351S 1836:Galactocerebroside 1708:GM2 gangliosidoses 1703:GM1 gangliosidoses 1591:External resources 893:10.1007/bf00208283 750:"Sandhoff Disease" 696:10.1007/bf00191799 626:10.1007/bf01732464 421: 292:metabolic disorder 227:ascertainment bias 212:Christian Maronite 118:hepatosplenomegaly 96:Symptoms and signs 1937: 1936: 1870: 1869: 1791:Gaucher's disease 1717:Tay–Sachs disease 1614: 1613: 858:"Carrier Testing" 839:on April 10, 2009 214:communities from 102:Tay–Sachs disease 90:Tay–Sachs disease 78: 77: 16:Medical condition 1977: 1787:Glucocerebroside 1776:SMPD1-associated 1712:Sandhoff disease 1680: 1669:Sphingolipidoses 1656:lipid metabolism 1641: 1634: 1627: 1618: 1492: 1481:Sandhoff Disease 1459: 1458: 1448: 1416: 1410: 1409: 1399: 1389: 1357: 1351: 1350: 1317:(894): 698–700. 1306: 1300: 1299: 1271: 1265: 1264: 1262: 1261: 1242: 1236: 1235: 1225: 1207: 1183: 1177: 1176: 1150: 1144: 1143: 1107: 1101: 1100: 1098: 1097: 1082: 1076: 1075: 1047: 1041: 1040: 1012: 1006: 1005: 976: 967: 966: 954: 948: 947: 919: 913: 912: 875: 869: 868: 866: 865: 854: 848: 847: 845: 844: 829: 820: 819: 809: 785: 776: 775: 767: 761: 760: 758: 757: 746: 740: 739: 737: 736: 725: 716: 715: 679: 666: 657: 646: 645: 609: 603: 602: 565: 559: 558: 540: 508: 497: 496: 468: 419:Sphingolipidoses 177: 126:bronchopneumonia 81:Sandhoff disease 74: 73: 49: 22:Sandhoff disease 19: 1985: 1984: 1980: 1979: 1978: 1976: 1975: 1974: 1940: 1939: 1938: 1933: 1898: 1866: 1843: 1804: 1795: 1750: 1746:Fabry's disease 1727: 1687: 1671: 1663: 1645: 1615: 1610: 1609: 1586: 1585: 1503: 1476: 1463: 1462: 1418: 1417: 1413: 1359: 1358: 1354: 1308: 1307: 1303: 1273: 1272: 1268: 1259: 1257: 1244: 1243: 1239: 1185: 1184: 1180: 1173: 1152: 1151: 1147: 1109: 1108: 1104: 1095: 1093: 1084: 1083: 1079: 1049: 1048: 1044: 1014: 1013: 1009: 978: 977: 970: 956: 955: 951: 921: 920: 916: 877: 876: 872: 863: 861: 856: 855: 851: 842: 840: 831: 830: 823: 787: 786: 779: 769: 768: 764: 755: 753: 748: 747: 743: 734: 732: 727: 726: 719: 681: 680: 669: 658: 649: 620:(21): 1189–91. 614:Klin Wochenschr 611: 610: 606: 567: 566: 562: 510: 509: 500: 470: 469: 456: 451: 434: 413: 396:anticonvulsants 391: 358:cherry-red spot 328: 284:genetic testing 272: 240: 238:Pathophysiology 201:the indigenous 183: 138: 98: 68: 17: 12: 11: 5: 1983: 1981: 1973: 1972: 1967: 1962: 1957: 1952: 1942: 1941: 1935: 1934: 1932: 1931: 1926: 1923:Wolman disease 1912: 1906: 1904: 1900: 1899: 1897: 1896: 1894:Batten disease 1891: 1886: 1880: 1878: 1872: 1871: 1868: 1867: 1865: 1864: 1862:Farber disease 1854: 1852: 1845: 1844: 1842: 1840:Krabbe disease 1833: 1828: 1819: 1817: 1816: 1815: 1812:leukodystrophy 1797: 1796: 1794: 1793: 1784: 1778: 1761: 1759: 1752: 1751: 1749: 1748: 1738: 1736: 1729: 1728: 1726: 1725: 1719: 1714: 1705: 1695: 1693: 1690:gangliosidoses 1677: 1665: 1664: 1646: 1644: 1643: 1636: 1629: 1621: 1612: 1611: 1608: 1607: 1595: 1594: 1592: 1588: 1587: 1584: 1583: 1572: 1561: 1550: 1535: 1520: 1504: 1499: 1498: 1496: 1495:Classification 1489: 1488: 1475: 1474:External links 1472: 1461: 1460: 1411: 1372:(8): 3979–83. 1352: 1301: 1266: 1237: 1198:(3): 550–563. 1178: 1172:978-0470016176 1171: 1145: 1102: 1077: 1058:(1): 139–145. 1042: 1023:(3): 328–333. 1007: 988:(1–2): 133–7. 968: 949: 924:Human Genetics 914: 881:Human Genetics 870: 849: 821: 800:(1): 338–345. 777: 762: 741: 717: 690:(4): 417–422. 684:Human Genetics 667: 647: 604: 577:(39): 1833–9. 560: 523:(4): 351–354. 498: 453: 452: 450: 447: 446: 445: 440: 433: 430: 412: 409: 390: 387: 378: 377: 373: 365: 327: 324: 271: 268: 239: 236: 223:Ashkenazi Jews 219: 218: 209: 199: 182: 179: 137: 134: 97: 94: 76: 75: 62: 56: 55: 51: 50: 42: 41: 28: 24: 23: 15: 13: 10: 9: 6: 4: 3: 2: 1982: 1971: 1968: 1966: 1965:Rare diseases 1963: 1961: 1958: 1956: 1953: 1951: 1948: 1947: 1945: 1930: 1927: 1924: 1920: 1916: 1913: 1911: 1908: 1907: 1905: 1901: 1895: 1892: 1890: 1887: 1885: 1882: 1881: 1879: 1877: 1873: 1863: 1859: 1856: 1855: 1853: 1851: 1846: 1841: 1837: 1834: 1832: 1829: 1827: 1823: 1820: 1818: 1813: 1810: 1809: 1808: 1803: 1798: 1792: 1788: 1785: 1782: 1779: 1777: 1773: 1770: 1769:phospholipid: 1766: 1765:Sphingomyelin 1763: 1762: 1760: 1758: 1757:sphingomyelin 1753: 1747: 1743: 1740: 1739: 1737: 1735: 1730: 1723: 1720: 1718: 1715: 1713: 1709: 1706: 1704: 1700: 1697: 1696: 1694: 1691: 1686: 1681: 1678: 1675: 1670: 1666: 1661: 1657: 1653: 1652:Inborn errors 1649: 1642: 1637: 1635: 1630: 1628: 1623: 1622: 1619: 1606: 1602: 1601: 1597: 1596: 1593: 1589: 1582: 1578: 1577: 1573: 1571: 1567: 1566: 1562: 1560: 1556: 1555: 1551: 1549: 1545: 1544: 1540: 1536: 1534: 1530: 1529: 1525: 1521: 1519: 1515: 1514: 1510: 1506: 1505: 1502: 1497: 1493: 1487: 1483: 1482: 1478: 1477: 1473: 1471: 1470: 1469: 1456: 1452: 1447: 1442: 1438: 1434: 1431:(7): 1201–5. 1430: 1426: 1422: 1415: 1412: 1407: 1403: 1398: 1393: 1388: 1383: 1379: 1375: 1371: 1367: 1363: 1356: 1353: 1348: 1344: 1340: 1336: 1332: 1328: 1324: 1320: 1316: 1312: 1305: 1302: 1297: 1293: 1289: 1285: 1281: 1277: 1270: 1267: 1256:on 2018-02-24 1255: 1251: 1247: 1241: 1238: 1233: 1229: 1224: 1219: 1215: 1211: 1206: 1201: 1197: 1193: 1189: 1182: 1179: 1174: 1168: 1164: 1160: 1156: 1149: 1146: 1141: 1137: 1133: 1129: 1125: 1121: 1117: 1113: 1106: 1103: 1092:on 2009-01-29 1091: 1087: 1081: 1078: 1073: 1069: 1065: 1061: 1057: 1053: 1046: 1043: 1038: 1034: 1030: 1026: 1022: 1018: 1011: 1008: 1003: 999: 995: 991: 987: 983: 975: 973: 969: 964: 960: 953: 950: 945: 941: 937: 933: 929: 925: 918: 915: 910: 906: 902: 898: 894: 890: 887:(3): 279–82. 886: 882: 874: 871: 859: 853: 850: 838: 834: 828: 826: 822: 817: 813: 808: 803: 799: 795: 791: 784: 782: 778: 773: 766: 763: 751: 745: 742: 730: 724: 722: 718: 713: 709: 705: 701: 697: 693: 689: 685: 678: 676: 674: 672: 668: 665: 661: 656: 654: 652: 648: 643: 639: 635: 631: 627: 623: 619: 615: 608: 605: 600: 596: 592: 588: 584: 580: 576: 572: 564: 561: 556: 552: 548: 544: 539: 534: 530: 526: 522: 518: 514: 507: 505: 503: 499: 494: 490: 486: 482: 478: 474: 467: 465: 463: 461: 459: 455: 448: 444: 441: 439: 436: 435: 431: 429: 425: 417: 410: 408: 405: 400: 397: 388: 386: 384: 374: 371: 366: 363: 359: 355: 351: 347: 343: 339: 334: 333: 332: 325: 323: 320: 314: 311: 306: 301: 297: 293: 289: 285: 281: 277: 269: 267: 264: 262: 258: 254: 250: 247: 246: 237: 235: 231: 228: 224: 217: 213: 210: 208: 204: 200: 198: 194: 193: 192: 189: 186: 180: 178: 176: 170: 165: 163: 159: 154: 150: 145: 143: 135: 133: 129: 127: 123: 119: 115: 111: 107: 103: 95: 93: 91: 86: 82: 72: 66: 65:Endocrinology 63: 61: 57: 52: 48: 43: 40: 36: 32: 29: 25: 20: 1807:sulfatidoses 1768: 1711: 1598: 1574: 1563: 1552: 1537: 1522: 1507: 1479: 1465: 1464: 1428: 1424: 1414: 1369: 1365: 1355: 1314: 1310: 1304: 1279: 1275: 1269: 1258:. Retrieved 1254:the original 1249: 1240: 1195: 1191: 1181: 1154: 1148: 1118:(2): 241–9. 1115: 1111: 1105: 1094:. Retrieved 1090:the original 1080: 1055: 1051: 1045: 1020: 1016: 1010: 985: 981: 962: 958: 952: 930:(1): 12–17. 927: 923: 917: 884: 880: 873: 862:. Retrieved 852: 841:. Retrieved 837:the original 797: 793: 771: 765: 754:. Retrieved 744: 733:. Retrieved 687: 683: 617: 613: 607: 574: 570: 563: 520: 516: 479:(6): 283–8. 476: 472: 426: 422: 401: 392: 379: 362:organomegaly 342:motor skills 329: 315: 309: 296:enzyme assay 273: 265: 260: 243: 241: 232: 225:may reflect 220: 207:Saskatchewan 190: 187: 184: 169:chromosome 5 166: 146: 139: 130: 106:gangliosides 99: 80: 79: 38: 34: 30: 1850:sphingosine 1699:Ganglioside 1685:ganglioside 172:exons 1–5. 27:Other names 1944:Categories 1722:AB variant 1576:DiseasesDB 1260:2018-02-23 1096:2009-05-03 864:2009-05-03 843:2009-05-03 756:2009-05-03 735:2009-05-03 449:References 313:mutation. 300:urinalysis 151:on the 14 1884:Infantile 1822:Sulfatide 1802:sulfatide 1734:globoside 1282:: 354–6. 1214:0022-2275 599:260064612 517:FEBS Lett 443:Globoside 389:Treatment 350:paralysis 270:Diagnosis 197:Argentina 162:Lysosomes 158:lysosomes 122:pneumonia 60:Specialty 1858:Ceramide 1674:ceramide 1600:Orphanet 1296:13957544 1232:29358305 1140:41447979 1132:15159655 1037:16569321 1002:11880123 944:10982028 712:39688704 662:(OMIM): 555:84542601 547:11947222 473:Life Sci 432:See also 346:dementia 1570:D012497 1455:6226523 1374:Bibcode 1347:8473726 1339:5793973 1319:Bibcode 1311:Science 1223:5832932 1072:8162015 909:9666991 901:8076944 807:1685463 704:7557963 642:1735733 634:5124584 591:5679107 525:Bibcode 493:5651108 411:History 338:muscles 110:enzymes 1781:type C 1559:268800 1533:E75.01 1453:  1446:555256 1443:  1425:EMBO J 1404:  1397:392913 1394:  1345:  1337:  1294:  1230:  1220:  1212:  1169:  1138:  1130:  1070:  1035:  1000:  965:: A48. 942:  907:  899:  816:414620 814:  804:  710:  702:  640:  632:  597:  589:  553:  545:  491:  383:ataxia 370:autism 348:, and 319:embryo 276:biopsy 216:Cyprus 149:codons 142:genome 136:Causes 67:  1903:Other 1800:From 1755:From 1732:From 1683:From 1581:29469 1548:330.1 1528:10-CM 1518:E75.0 1486:NINDS 1406:99746 1343:S2CID 1136:S2CID 905:S2CID 708:S2CID 638:S2CID 595:S2CID 551:S2CID 376:span. 352:. An 326:Types 288:cells 280:liver 203:MĂ©tis 153:exons 124:, or 1672:(to 1565:MeSH 1554:OMIM 1543:9-CM 1451:PMID 1402:PMID 1335:PMID 1292:PMID 1228:PMID 1210:ISSN 1167:ISBN 1128:PMID 1068:PMID 1033:PMID 998:PMID 940:PMID 897:PMID 812:PMID 700:PMID 630:PMID 587:PMID 543:PMID 489:PMID 310:HEXB 261:HEXB 255:and 249:gene 245:HEXB 1876:NCL 1848:To 1654:of 1605:796 1539:ICD 1524:ICD 1509:ICD 1484:at 1441:PMC 1433:doi 1392:PMC 1382:doi 1327:doi 1315:165 1284:doi 1218:PMC 1200:doi 1159:doi 1120:doi 1060:doi 1025:doi 990:doi 986:318 932:doi 928:107 889:doi 802:PMC 692:doi 622:doi 579:doi 533:doi 481:doi 354:eye 305:DNA 294:), 205:in 120:), 37:or 1946:: 1860:: 1838:: 1824:: 1789:: 1767:: 1744:: 1701:: 1650:: 1603:: 1579:: 1568:: 1557:: 1546:: 1531:: 1516:: 1513:10 1449:. 1439:. 1427:. 1423:. 1400:. 1390:. 1380:. 1370:75 1368:. 1364:. 1341:. 1333:. 1325:. 1313:. 1290:. 1280:70 1278:. 1248:. 1226:. 1216:. 1208:. 1196:59 1194:. 1190:. 1165:. 1157:. 1134:. 1126:. 1116:27 1114:. 1066:. 1054:. 1031:. 1021:12 1019:. 996:. 984:. 971:^ 963:37 961:. 938:. 926:. 903:. 895:. 885:94 883:. 824:^ 810:. 798:30 796:. 792:. 780:^ 720:^ 706:. 698:. 688:96 686:. 670:^ 650:^ 636:. 628:. 618:49 616:. 593:. 585:. 575:93 573:. 549:. 541:. 531:. 519:. 515:. 501:^ 487:. 475:. 457:^ 282:, 128:. 33:, 1925:) 1921:/ 1917:( 1814:) 1805:( 1783:) 1774:( 1724:) 1710:( 1692:) 1688:( 1676:) 1662:) 1658:( 1640:e 1633:t 1626:v 1541:- 1526:- 1511:- 1501:D 1457:. 1435:: 1429:2 1408:. 1384:: 1376:: 1349:. 1329:: 1321:: 1298:. 1286:: 1263:. 1234:. 1202:: 1175:. 1161:: 1142:. 1122:: 1099:. 1074:. 1062:: 1056:3 1039:. 1027:: 1004:. 992:: 946:. 934:: 911:. 891:: 867:. 846:. 818:. 759:. 738:. 714:. 694:: 644:. 624:: 601:. 581:: 557:. 535:: 527:: 521:4 495:. 483:: 477:7

Index


Specialty
Endocrinology
Edit this on Wikidata
lipid storage disorder
Tay–Sachs disease
Tay–Sachs disease
gangliosides
enzymes
central nervous system
hepatosplenomegaly
pneumonia
bronchopneumonia
genome
codons
exons
lysosomes
Lysosomes
chromosome 5
align=left
Argentina
MĂ©tis
Saskatchewan
Christian Maronite
Cyprus
Ashkenazi Jews
ascertainment bias
HEXB
gene
beta-hexosaminidase A

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.

↑